Ikaros is a mutational target for lymphomagenesis in Mlh1-deficient mice

Oncogene

Volumn 26, Issue 20, 2007, Pages 2945-2949

  Kakinuma, S ^a   Kodama, Y ^a,b   Amasaki, Y ^a   Yi, S ^a   Tokairin, Y ^c   Arai, M ^d   Nishimura, M ^a   Monobe, M ^b   Kojima, S ^b   Shimada, Y ^a  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b TOKYO UNIVERSITY OF SCIENCE   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d CANCER INSTITUTE HOSPITAL   (Japan)

Author keywords

Coding microsatellites; DNA mismatch repair; Microsatellite instability; Mutational target gene; T cell lymphoma

Indexed keywords

IKAROS TRANSCRIPTION FACTOR; PROTEIN MLH1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FRAMESHIFT MUTATION; GENE DELETION; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; LYMPHOID CELL; MOUSE; MOUSE STRAIN; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION CARCINOGENESIS; RNA SPLICING; SEQUENCE ANALYSIS; STOP CODON; T CELL LYMPHOMA;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BASE SEQUENCE; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; FRAMESHIFT MUTATION; IKAROS TRANSCRIPTION FACTOR; LYMPHOMA; MICE; MICE, KNOCKOUT; NUCLEAR PROTEINS;

MUS;

EID: 34247877677     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210100     Document Type: Article

References (33)

1. Baker SM, Plug AW, Prolla TA, Bronner CE, Harris AC, Yao X et al. (1996). Involvement of mouse Mlh1 in DNA mismatch repair and meiotic crossing over. Nat Genet 13: 336-342.
2. Baross-Francis A, Makhani N, Liskay RM, Jirik FR. (2001). Elevated mutant frequencies and increased C: G → T: A transitions in Mlh1-/- versus Pms2-/- murine small intestinal epithelial cells. Oncogene 20: 619-625.
3. Bronner CE, Baker SM, Morrison PT, Warren G, Smith LG, Lescoe MK et al. (1994). Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 368: 258-261.
4. Campbell MR, Thang TY, Jirik FR, Andrew SE. (2000). Candidate mutator genes in mismatch repair-deficient thymic lymphomas: no evidence of mutations in the DNA polymerase delta gene. Carcinogenesis 21: 2281-2285.
5. De Vos M, Hayward BE, Charlton R, Taylor GR, Glaser AW, Picton S et al. (2006). PMS2 mutations in childhood cancer. J Natl Cancer Inst 98: 358-361.
6. Duval A, Hamelin R. (2002). Mutations at coding repeat sequences in mismatch repair-deficient human cancers: toward a new concept of target genes for instability. Cancer Res 62: 2447-2454.
7. Fishel R, Lescoe MK, Rao MR, Copeland NG, Jenkins NA, Garber J et al. (1993). The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75: 1027-1038.
8. Georgopoulos K, Moore DD, Derfler B. (1992). Ikaros, an early lymphoid-specific transcription factor and a putative mediator for T cell commitment. Science 258: 808-812.
9. Gu L, Cline-Brown B, Zhang F, Qiu L, Li GM. (2002). Mismatch repair deficiency in hematological malignancies with microsatellite instability. Oncogene 21: 5758-5764.
10. Kabbarah O, Mallon MA, Pfeifer JD, Edelmann W, Kucherlapati R, Goodfellow PJ. (2003). A panel of repeat markers for detection of microsatellite instability in murine tumors. Mol Carcinogen 38: 155-159.
11. Kakinuma S, Nishimura M, Kubo A, Nagai JY, Amasaki Y, Majima HJ et al. (2005). Frequent retention of heterozygosity for point mutations in p53 and Ikaros in N-ethyl-N-nitrosourea-induced mouse thymic lymphomas. Mutat Res 572: 132-141.
12. Kakinuma S, Nishimura M, Sasanuma S, Mita K, Suzuki G, Katsura Y et al. (2002). Spectrum of Znfn1a1 (Ikaros) inactivation and its association with loss of heterozygosity in radiogenic T-cell lymphomas in susceptible B6C3F1 mice. Radiat Res 157: 331-340.
13. Karlsson A, Soderkvist P, Zhuang SM. (2002). Point mutations and deletions in the znfn1a1/ikaros gene in chemically induced murine lymphomas. Cancer Res 62: 2650-2653.
14. Leach FS, Nicolaides NC, Papadopoulos N, Liu B, Jen J, Parsons R et al. (1993). Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 75: 1215-1225.
15. Lowsky R, Magliocco A, Ichinohasama R, Reitmair A, Scott S, Henry M et al. (2000). MSH2-deficient murine lymphomas harbor insertion/deletion mutations in the transforming growth factor beta receptor type 2 gene and display low not high frequency microsatellite instability. Blood 95: 1767-1772.
16. Nakanishi M, Tanaka K, Takahashi T, Kyo T, Dohy H, Fujiwara M et al. (2001). Microsatellite instability in acute myelocytic leukaemia developed from A-bomb survivors. Int J Radiat Biol 77: 687-694.
17. Nakayama H, Ishimaru F, Avitahl N, Sezaki N, Fujii N, Nakase K et al. (1999). Decreases in Ikaros activity correlate with blast crisis in patients with chronic myelogenous leukemia. Cancer Res 59: 3931-3934.
18. Okano H, Saito Y, Miyazawa T, Shinbo T, Chou D, Kosugi S et al. (1999). Homozygous deletions and point mutations of the Ikaros gene in gamma-ray-induced mouse thymic lymphomas. Oncogene 18: 6677-6683.
19. Papadopoulos N, Nicolaides NC, Wei YF, Ruben SM, Carter KC, Rosen CA et al. (1994). Mutation of a mutL homolog in hereditary colon cancer. Science 263: 1625-1629.
20. Papathanasiou P, Perkins AC, Cobb BS, Ferrini R, Sridharan R, Hoyne GF et al. (2003). Widespread failure of hematolymphoid differentiation caused by a recessive niche-filling allele of the Ikaros transcription factor. Immunity 19: 131-144.
21. Parsons R, Li GM, Longley MJ, Fang WH, Papadopoulos N, Jen J et al. (1993). Hypermutability and mismatch repair deficiency in RER + tumor cells. Cell 75: 1227-1236.
22. Reitmair AH, Schmits R, Ewel A, Bapat B, Redston M, Mitri A et al. (1995). MSH2 deficient mice are viable and susceptible to lymphoid tumours. Nat Genet 11: 64-70.
23. Ricciardone MD, Ozcelik T, Cevher B, Ozdag H, Tuncer M, Gurgey A et al. (1999). Human MLH1 deficiency predisposes to hematological malignancy and neurofibromatosis type 1. Cancer Res 59: 290-293.
24. Shimada Y, Nishimura M, Kakinuma S, Ogiu T, Fujimoto H, Kubo A et al. (2003). Genetic susceptibility to thymic lymphomas and K-ras gene mutation in mice after exposure to X-rays and N-ethyl-N-nitrosourea. Int J Radiat Biol 79: 423-430.
25. Shimada Y, Nishimura M, Kakinuma S, Okumoto M, Shiroishi T, Clifton KH et al. (2000). Radiation-associated loss of heterozygosity at the Znfn1a1 (Ikaros) locus on chromosome 11 in murine thymic lymphomas. Radiat Res 154: 293-300.
26. Sun L, Crotty ML, Sensel M, Sather H, Navara C, Nachman J et al. (1999a). Expression of dominant-negative Ikaros isoforms in T-cell acute lymphoblastic leukemia. Clin Cancer Res 5: 2112-2120.
27. Sun L, Heerema N, Crotty L, Wu X, Navara C, Vassilev A et al. (1999b). Expression of dominant-negative and mutant isoforms of the antileukemic transcription factor Ikaros in infant acute lymphoblastic leukemia. Proc Natl Acad Sci USA 96: 680-685.
28. Tokairin Y, Kakinuma S, Arai M, Nishimura M, Okamoto M, Ito E et al. (2006). Accelerated growth of intestinal tumours after radiation exposure in Mlh1-knockout mice: evaluation of the late effect of radiation on a mouse model of HNPCC. Int J Exp Pathol 87: 89-99.
29. Wang JH, Nichogiannopoulou A, Wu L, Sun L, Sharpe AH, Bigby M et al. (1996). Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation. Immunity 5: 537-549.
30. Wang Q, Desseigne F, Lasset C, Saurin JC, Navarro C, Yagci T et al. (1997). Germline hMSH2 and hMLH1 gene mutations in incomplete HNPCC families. Int J Cancer 73: 831-836.
31. Winandy S, Wu P, Georgopoulos K. (1995). A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma. Cell 83: 289-299.
32. Woerner SM, Kloor M, Mueller A, Rueschoff J, Friedrichs N, Buettner R et al. (2005). Microsatellite instability of selective target genes in HNPCC-associated colon adenomas. Oncogene 24: 2525-2535.
33. Yao X, Buermeyer AB, Narayanan L, Tran D, Baker SM, Prolla TA et al. (1999). Different mutator phenotypes in Mlh1- versus Pms2-deficient mice. Proc Natl Acad Sci USA 96: 6850-6855.